Armine Smith, M.D. is the director of urologic oncology at the Kimmel Cancer Center at Sibley Memorial Hospital, and an associate clinical professor of urology at the Brady Urological Institute of Johns Hopkins University School of Medicine. She is a member of Greenberg Bladder Cancer Institute and the director of Women's Bladder Cancer Program at Sibley Memorial Hospital. She is also a Mary and Armeane Choksi Scholar. Dr. Smith earned her medical degree from the University of California in San Francisco. She completed a residency in urology at the Cleveland Clinic, followed by a fellowship in urologic oncology at the National Cancer Institute, where she focused on development of personalized targeted therapies for bladder cancer. Dr. Smith is a member of the Society of Urologic Oncology, American Association of Cancer Research and American Urological Association. She has been selected multiple times as a Washington, DC and Virginia top urologist. Dr. Smith specializes in advanced open, minimally invasive and robotic urologic surgery for urologic malignancies, including bladder and upper tract urothelial cancer, kidney cancer, testicular cancer, penile and urethral cancer. In bladder cancer surgery she specializes in bladder preservation, complex urinary diversions, including continent orthotopic neobladder and continent catheterizable Indiana pouch techniques. In kidney cancer, her expertise focuses on partial nephrectomy, with the goal of oncologically-sound maximum nephron-sparing surgery. She has contributed to various research, publications and presentations on topics of urology. Dr. Smith has made TV appearances, lectured domestically and internationally, and authored chapters on urothelial and kidney cancer. Her current research focuses on elucidation of risk factors for bladder cancer development, oncologically safe organ preservation in both men and women with bladder and kidney cancer and improving outcomes from bladder cancer treatments. Listen to Dr. Smith’s Cancer Matters podcast episode to learn more about her work. Dr. Smith is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. Her top areas of expertise are Bladder Cancer, Muscle Invasive Bladder Cancer, Urothelial Cancer, Cystectomy, and Reconstructive Urology Surgery.

Sekwon Jang is a Hematologist Oncology specialist and an Oncologist in Falls Church, Virginia. Dr. Jang is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Cutaneous T-Cell Lymphoma (CTCL), and Squamous Cell Skin Carcinoma. Dr. Jang is currently accepting new patients.

Mark Goldstein is a Hematologist Oncology provider in Bethesda, Maryland. Dr. Goldstein is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Childhood Iron Deficiency Anemia, Anal Cancer, Myelodysplastic Syndrome (MDS), and Pleuropulmonary Blastoma.

Dr. Kathleen Sterling is part of the Suburban Hospital’s medical staff and a urologist with Urological Consultants, P.A. Dr. Sterling served as chief resident of the University of Maryland Medical Center urology program. During her training, she performed laboratory research related to overactive bladder. With an undergraduate degree from Vanderbilt University, Dr. Sterling served as a Surface Warfare Officer in the United States Navy, completing two deployments at sea, including one combat mission during Operation Iraqi Freedom. Dr. Sterling treats both men and women. Her expertise includes voiding dysfunction, male and female urinary incontinence and female pelvic floor disorders. Dr. Sterling’s practice also encompasses medical and surgical management of kidney stones, erectile dysfunction and urological cancers. Dr. Sterling sees patients in Bethesda and Germantown, Maryland. For appointments, call 301-530-1700. Dr. Sterling is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. Her top areas of expertise are Urinary Tract Infection in Children, Urinary Tract Infection (UTI), Urinary Incontinence, Kidney Stones, and Ureteroscopy.

Raj Manchandani is a Hematologist and an Oncologist in Reston, Virginia. Dr. Manchandani is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Mycosis Fungoides, Anemia, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Manchandani is currently accepting new patients.

Gregory Schenk is an Urologist in Reston, Virginia. Dr. Schenk is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Schenk is currently accepting new patients.

Jennifer Young is an Urologist in Reston, Virginia. Dr. Young is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. Her top areas of expertise are Obstructive Uropathy, Bilateral Hydronephrosis, Hydronephrosis, Prostatectomy, and Ureteroscopy. Dr. Young is currently accepting new patients.

Christine Tran is an Urologist in Reston, Virginia. Dr. Tran is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. Her top areas of expertise are Urinary Tract Infection in Children, Boils, Kidney Stones, Ureteroscopy, and Nephrectomy. Dr. Tran is currently accepting new patients.

Dr. Rosenblum is originally from Mexico City. He received his medical degree from the Anahuac University where he graduated at the top of his class. He then competed for and was awarded a urology residency position at the prestigious National Institute of Medical Sciences in Mexico. He subsequently accepted a fellowship position in urologic oncology at the University of Colorado Health Sciences Center in Denver, where he was involved in multiple research projects relating to urologic cancers–in particular, prostate cancer treatments and prostate cancer chemoprevention. Upon completing his fellowship, Dr. Rosenblum emigrated to the United States and became board eligible by completing his second urology residency at the Washington Hospital Center in Washington, D.C. He is a diplomate of the American Board of Urology. Dr. Rosenblum has been in private practice since 2005. He also volunteers as a consultant for the Montgomery County Cancer Crusade. He has a diverse urologic practice with particular interests in minimally invasive surgery for urologic cancers. Dr. Rosenblum has published multiple journal articles and meeting abstracts, and he has been an invited lecturer both here and abroad. He has received multiple awards and distinctions along the course of his career. Dr. Rosenblum is a member of the American Urological Associationand a Fellow of the American College of Surgeons. When he is not caring for patients, Dr. Rosenblum enjoys spending time with his wife, two small daughters, and his dog, Lucas. Dr. Rosenblum is rated as an Advanced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Enlarged Prostate (BPH), Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Nephrectomy.

Robert Mordkin is an Urologist in Arlington, Virginia. Dr. Mordkin is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Prostate Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Mordkin is currently accepting new patients.

Dr. Channing J. Paller is a medical oncologist at Sibley Memorial Hospital and a professor of oncology at the Johns Hopkins University School of Medicine. She practices out of the Prostate Cancer Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, D.C., and the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins in Baltimore, MD. Dr. Paller has expertise in prostate, bladder, kidney, and testicular cancer. Dr. Paller earned her medical degree from Harvard Medical School and completed a residency in internal medicine, followed by a fellowship in hematology and oncology at Johns Hopkins University School of Medicine. In addition, Dr. Paller completed a rotation with the chief of the Investigational Drug Branch at the National Cancer Institute (NCI) Cancer Therapy Evaluation Program and a rotation with the associate director for regulatory science in the Office of Oncology Drug Products at the Food and Drug Administration. She also completed rotations at the Weizmann Institute of Israel’s Department of Biological Regulation and McCord Hospital in South Africa, where she participated in the Harvard AIDS project. In 2016, Dr. Paller was one of only five oncologists awarded the NCI Mentored Patient-Oriented Research Career Development Award. In 2015, she received the 2015 Passano Clinician Scientist Award for early-stage research that is already making a contribution to science. Earlier in her career, she was selected for both a 2011-2012 Young Investigator Award by the American Society of Clinical Oncology and for the 2011-12 Eastern Cooperative Oncology Group Paul Carbone Award. Dr. Paller is a member of the American Society of Clinical Oncology and the American Association for Cancer Research. Dr. Paller’s research focuses on evaluating new therapies for prostate cancer, particularly combination therapies that engage the immune system. She is the principal investigator on two multi-site clinical trials and was the first author on the NCI Investigational Drug Steering Committee publication, “Consensus Recommendations on the Phase I Combination Clinical Trials of the Clinical Trial Design Task Force.” Dr. Paller was the chair for the oral abstract session on genitourinary cancer at the 2015 Annual Meeting of the American Society of Clinical Oncology and she is currently funded by an NCI immunotherapy grant to look at combination therapies that link standard of care therapy with inhibition of transforming growth factor beta in prostate cancer. She is also opening trials of vitamin C with chemotherapy in prostate cancer and of mistletoe in all solid tumors. Dr. Paller is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. Her top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Muscle Invasive Bladder Cancer, Hormone Replacement Therapy (HRT), and Prostatectomy.

Andrew Joel is an Urologist in Arlington, Virginia. Dr. Joel is rated as a Distinguished provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Muscle Invasive Bladder Cancer, Prostate Cancer, Familial Prostate Cancer, Ureteroscopy, and Reconstructive Urology Surgery. Dr. Joel is currently accepting new patients.

Timothy Kim is an Urologist in Mclean, Virginia. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Renal Cell Carcinoma (RCC), Urothelial Cancer, Prostate Cancer, Nephrectomy, and Thrombectomy.

Karen Riedy is a Radiologist and a Neuroradiologist in Vienna, Virginia. Dr. Riedy is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. Her top areas of expertise are Pleurisy, Pleural Effusion, Progressive Familial Intrahepatic Cholestasis Type 1, and Progressive Familial Intrahepatic Cholestasis Type 2. Dr. Riedy is currently accepting new patients.

David Dubois is an Interventional Radiologist and a Radiologist in Reston, Virginia. Dr. Dubois is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Stroke, Small Cell Lung Cancer (SCLC), Cerebelloolivary Atrophy, Gastrostomy, and Bone Marrow Aspiration. Dr. Dubois is currently accepting new patients.

Gary Fialk is an Urologist in Reston, Virginia. Dr. Fialk is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Kidney Stones, Boils, Folliculitis, Ureteroscopy, and Prostatectomy.

Chuck Pruna is an Urologist in Reston, Virginia. Dr. Pruna is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are UPJ Obstruction, Kidney Stones, Boils, Ureteroscopy, and Prostatectomy. Dr. Pruna is currently accepting new patients.

Mei-hwa Firestone is a Hematologist Oncology specialist and a Hematologist in Reston, Virginia. Dr. Firestone has been practicing medicine for over 17 years and is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Lung Cancer. Dr. Firestone is currently accepting new patients.

John Pahira is an Urologist in Reston, Virginia. Dr. Pahira is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Perirenal Abscess, Carbuncle, Kidney Stones, Boils, and Ureteroscopy. Dr. Pahira is currently accepting new patients.

Jong-ho Choi is a Radiologist and an Interventional Radiologist in Herndon, Virginia. Dr. Choi is rated as an Experienced provider by MediFind in the treatment of Urothelial Cancer. His top areas of expertise are Bronchiectasis, Pleurisy, Pleural Effusion, Visceromegaly, and Bone Marrow Aspiration. Dr. Choi is currently accepting new patients.